Cat. No.: DIA-0230906
Product Information | |
---|---|
CAS No. | 1374598-80-7 |
Formula | C58H66O15S2 |
Molecular Weight | 533.63 |
SMILES | O.CC1=C(C(=CC(=C1)OCCC[S](C)(=O)=O)C)C2=CC=CC(=C2)COC3=CC=C4C(COC4=C3)CC(O)=O.CC5=C(C(=CC(=C5)OCCC[S](C)(=O)=O)C)C6=CC=CC(=C6)COC7=CC=C8C(COC8=C7)CC(O)=O |
Product Description | Fasiglifam (TAK-875) is a selective GPR40 agonist with EC50 of 14 nM in human GPR40 expressing CHO cell line, 400-fold more potent than oleic acid. |
Format & Storage | |
---|---|
Purity | > 98% |
Shipping | Shipped on dry ice. |
Storage | Powder: -20 °C, 3 years; 4 °C, 2 years In solvent: -80 °C, 6 months; -20 °C, 1 month |
Solubility Overview | Soluble in DMSO |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.